BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for CAREDX, INC. · Molecular diagnostics

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · $50,000.00 income · posted Apr 16, 2025

Lobbying activity 1

Health Issues

Use of bioscience markers with regard to organ transplant rejection

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem